We are N-(biphenyl-4-yl)-N-(4′-broMobiphenyl-4-yl)-9,9-diMethyl-9H-fluoren-2-amine CAS:1268621-99-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Related News: In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.3-Bromo-5-methylpicolinic acid CAS:1211515-68-2 The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development.2-Bromo-1-(4-methylsulfanylphenyl)ethanone Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.3-Glycidoxypropyltrimethoxysilane Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.
Product Name | |
---|---|
5-(Acetamido)-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide Cas:31127-80-7 | View Details |
TRIS-(4-AMINOPHENYL)THIOPHOSPHATE Cas:52664-35-4 | View Details |
2,5-Bis(trifluoromethyl)aniline | View Details |